Paper30822331
Detoxification therapy of traditional Chinese medicine for genital tract high-risk human papillomavirus infection: A systematic review and meta-analysis.
Luo M and 5 others. PLoS One, 2019. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Detoxification therapy of traditional Chinese medicine for genital tract high-risk human papillomavirus infection: A systematic review and meta-analysis. Papers, record 30822331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30822331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drugs, Chinese Herbal | Major topic |
| Medicine, Chinese Traditional | Major topic |
| Papillomavirus Infections | Major topic |
| Reproductive Tract Infections | Major topic |
| Female | |
| Humans | |
| Randomized Controlled Trials as Topic |
Source PubMed
References13
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23146675 | Prevalence, incidence and persistence of genital HPV infections in a large cohort of sexually active young women in the Netherlands. | Vaccine | 2013 | https://conductscience.org/library/papers/23146675 | PubMed |
| 2 | 264754 | Cytology of gynecologic condyloma acuminatum. | Acta Cytol | 1977 | https://conductscience.org/library/papers/264754 | PubMed |
| 3 | 1069445 | Condylomatous lesions of the cervix and vagina. I. Cytologic patterns. | Acta Cytol | 1976 | https://conductscience.org/library/papers/1069445 | PubMed |
| 4 | 29284025 | Clinical management and risk reduction in women with low-grade squamous intraepithelial lesion cytology: A population-based cohort study. | PLoS One | 2017 | https://conductscience.org/library/papers/29284025 | PubMed |
| 5 | 28124442 | Patterns of persistent HPV infection after treatment for cervical intraepithelial neoplasia (CIN): A systematic review. | Int J Cancer | 2017 | https://conductscience.org/library/papers/28124442 | PubMed |
| 6 | 28953116 | Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines. | J Low Genit Tract Dis | 2017 | https://conductscience.org/library/papers/28953116 | PubMed |
| 7 | 15547627 | Herbs or natural products that protect against cancer growth part three of a four-part series. | Oncol Nurs Forum | 2004 | https://conductscience.org/library/papers/15547627 | PubMed |
| 8 | 23185761 | [Therapeutic efficacy of youdujing preparation in treating cervical high-risk human papilloma virus infection patients]. | Zhongguo Zhong Xi Yi Jie He Za Zhi | 2012 | https://conductscience.org/library/papers/23185761 | PubMed |
| 9 | 23635684 | 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. | Obstet Gynecol | 2013 | https://conductscience.org/library/papers/23635684 | PubMed |
| 10 | 26564504 | [Natural Outcome of Genital Tract High-risk Human Papillomavirus Infection and Associated Factors among 760 Women]. | Zhongguo Yi Xue Ke Xue Yuan Xue Bao | 2015 | https://conductscience.org/library/papers/26564504 | PubMed |
| 11 | 17342094 | High-risk HPV type-specific clearance rates in cervical screening. | Br J Cancer | 2007 | https://conductscience.org/library/papers/17342094 | PubMed |
| 12 | 22133884 | The known unknowns of HPV natural history. | J Clin Invest | 2011 | https://conductscience.org/library/papers/22133884 | PubMed |
| 13 | 26695583 | Practice Bulletin No. 157: Cervical Cancer Screening and Prevention. | Obstet Gynecol | 2016 | https://conductscience.org/library/papers/26695583 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38420364 | Effect of different interventions on the treatment of high-risk human papillomavirus infection: a systematic review and network meta-analysis. | Front Med (Lausanne) | 2024 | https://conductscience.org/library/papers/38420364 | PubMed |
| 37692777 | Effect of heat-clearing and dampness-eliminating Chinese medicine for high-risk cervical cancer papillomavirus infection: a systematic review and meta-analysis of randomized controlled trials. | Front Med (Lausanne) | 2023 | https://conductscience.org/library/papers/37692777 | PubMed |
| 37576405 | Comparative Efficacy and Safety of Chinese Patent Medicines for Cervical High-risk Human Papillomavirus Infection: A Bayesian Network Meta-analysis. | J Cancer | 2023 | https://conductscience.org/library/papers/37576405 | PubMed |
| 34925532 | Functions of Traditional Chinese Medicine Combined with Recombinant Human Interferon α2b in Cervical Intraepithelial Neoplasias Patients. | Evid Based Complement Alternat Med | 2021 | https://conductscience.org/library/papers/34925532 | PubMed |
| 34621324 | Effect of Psychological Care Combined with Traditional Chinese Medicine on Postoperative Psychological Stress Response in Patients with Advanced Cervical Cancer. | Evid Based Complement Alternat Med | 2021 | https://conductscience.org/library/papers/34621324 | PubMed |
| 34603461 | Clinical Effects of Chinese Herbal Decoction Combined with Basic Chemoradiotherapy and Nursing Intervention in the Treatment of Cervical Cancer and the Effect on Serum CEA, CA125, and TNF-α Levels. | Evid Based Complement Alternat Med | 2021 | https://conductscience.org/library/papers/34603461 | PubMed |
| 34070706 | Current Updates on Cancer-Causing Types of Human Papillomaviruses (HPVs) in East, Southeast, and South Asia. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34070706 | PubMed |
| 33552075 | Nocardia Rubra Cell Wall Skeleton Up-Regulates T Cell Subsets and Inhibits PD-1/PD-L1 Pathway to Promote Local Immune Status of Patients With High-Risk Human Papillomavirus Infection and Cervical Intraepithelial Neoplasia. | Front Immunol | 2020 | https://conductscience.org/library/papers/33552075 | PubMed |
| 32849905 | Zhidai Decoction Inhibits Cervical Cancer through Regulation of Vaginal Microbiota. | Evid Based Complement Alternat Med | 2020 | https://conductscience.org/library/papers/32849905 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| IFNA1 | 3439 | PubTator's text mining | https://conductscience.org/library/genes/3439 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30822331
GET https://conductscience.org/api/papers/v1/30822331/authors